⚡From the panel
Prof Chen-Yuan Chiang highlighted why MDR-TB remains hard to control in LMICs.
Undetected cases, gaps in resistance testing, early loss to follow-up and limited access to effective short regimens all continue to drive poor outcomes and resistance.
🔗Join: bit.ly/3NTXxZG
#ACC2026 “No one should die from TB.”
Dr Wanatpreeya Phongsamart emphasized that equity in TB care means prioritizing pregnant women and children, who face high mortality yet remain underrepresented in research and trials🤱👶
💭🔗 Join us: bit.ly/3NTXxZG
#ACC2026 🌙✨That brings us to the end of today’s final session at #ACC2026
Key themes from the panel included protecting new TB drugs through stewardship, ensuring children are not left behind in care and monitoring, and more.
🙌Thank you for joining the discussion.
💥More exciting sessions coming tomorrow! 
